Our academic collaborators’ seminal contributions push the field forward
Our constellation of renowned thinkers and partners
The right collaborators across pharma, biotech and nonprofit
The next generation of scientific leaders in cancer immunotherapy
Stories & Announcements
PICI in the News
Resources for Press
Five Years of Transforming Cancer Immunotherapy Research, Five Promises Kept
New CAR-T Approach Could Overcome Resistance, Avoid Relapse in Some Cancer Patients
Funding the Future of Cancer Research: The Parker Institute for Cancer Immunotherapy Awards Nearly $3 Million to Six Early Career Researchers
Develop breakthrough immune therapies to turn all cancers into curable diseases faster
The driving force behind PICI’s research and operations
Transformative science requires visionary philanthropy
Join us. Change lives.
Accelerate Breakthrough Research – From Discovery to Commercialization
A fundamental challenge in cancer research is how to bring the best ideas to the marketplace, as complex intellectual property and patent processes can be hard to navigate. Enter PICI. Our legal experts and financial support help our investigators turn their discoveries into treatments. We evaluate a discovery’s potential, ensure patent applications are compelling, and help optimize and negotiate licensing. This catalyzes their discoveries to make a real impact for patients faster.
Invention Disclosures Reviewed
We have extensive expertise in immuno-oncology patents and provide strategic guidance and advice throughout the process.
William Healey Smith, PhD, JD
Senior Director, Intellectual Property and Licensing
PICI offers a unique combination of expertise, resources and capabilities.
Our approach means investigators can bring life-saving discoveries to patients more efficiently. Though we broker the process, the researcher’s institution retains ownership of the invention.